2017 Q3 Form 10-Q Financial Statement
#000114420417059983 Filed on November 17, 2017
Income Statement
Concept | 2017 Q3 | 2016 Q3 |
---|---|---|
Revenue | $15.11K | $0.00 |
YoY Change | ||
Cost Of Revenue | $52.38K | $0.00 |
YoY Change | ||
Gross Profit | -$37.28K | $0.00 |
YoY Change | ||
Gross Profit Margin | -246.78% | |
Selling, General & Admin | $605.5K | |
YoY Change | ||
% of Gross Profit | ||
Research & Development | $157.9K | $14.09K |
YoY Change | 1020.48% | |
% of Gross Profit | ||
Depreciation & Amortization | $0.00 | $0.00 |
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $802.1K | $198.1K |
YoY Change | 304.92% | |
Operating Profit | -$839.4K | -$198.1K |
YoY Change | 323.74% | |
Interest Expense | $142.00 | |
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | $142.00 | $756.00 |
YoY Change | -81.22% | |
Pretax Income | -$839.1K | -$197.3K |
YoY Change | 325.19% | |
Income Tax | $200.00 | $200.00 |
% Of Pretax Income | ||
Net Earnings | -$839.3K | -$197.5K |
YoY Change | 324.86% | |
Net Earnings / Revenue | -5555.75% | |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | ||
COMMON SHARES | ||
Basic Shares Outstanding | 596.2K shares | 1.721M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2017 Q3 | 2016 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.650M | |
YoY Change | ||
Cash & Equivalents | $1.653M | $50.30K |
Short-Term Investments | ||
Other Short-Term Assets | $8.727K | |
YoY Change | ||
Inventory | $28.08K | |
Prepaid Expenses | ||
Receivables | $30.00K | |
Other Receivables | $0.00 | |
Total Short-Term Assets | $1.858M | |
YoY Change | ||
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $33.36K | |
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $33.36K | |
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | $1.858M | |
Total Long-Term Assets | $33.36K | |
Total Assets | $1.891M | |
YoY Change | ||
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $760.0K | |
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $810.0K | |
YoY Change | ||
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $810.0K | |
Total Long-Term Liabilities | $0.00 | |
Total Liabilities | $810.0K | |
YoY Change | ||
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $1.080M | |
YoY Change | ||
Total Liabilities & Shareholders Equity | $1.890M | |
YoY Change |
Cashflow Statement
Concept | 2017 Q3 | 2016 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$839.3K | -$197.5K |
YoY Change | 324.86% | |
Depreciation, Depletion And Amortization | $0.00 | $0.00 |
YoY Change | ||
Cash From Operating Activities | -$540.0K | -$660.0K |
YoY Change | -18.18% | |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$20.00K | $0.00 |
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | $0.00 |
YoY Change | ||
Cash From Investing Activities | -$10.00K | $0.00 |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 0.000 | 550.0K |
YoY Change | -100.0% | |
NET CHANGE | ||
Cash From Operating Activities | -540.0K | -660.0K |
Cash From Investing Activities | -10.00K | 0.000 |
Cash From Financing Activities | 0.000 | 550.0K |
Net Change In Cash | -550.0K | -110.0K |
YoY Change | 400.0% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$540.0K | -$660.0K |
Capital Expenditures | -$20.00K | $0.00 |
Free Cash Flow | -$520.0K | -$660.0K |
YoY Change | -21.21% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2017Q3 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
26006 | USD |
CY2016Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
30000 | USD |
CY2016Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
6900 | USD |
CY2017Q3 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
0 | USD |
CY2017Q3 | us-gaap |
Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
|
0 | USD |
CY2016Q4 | us-gaap |
Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
|
2000 | USD |
CY2017Q3 | us-gaap |
Inventory Net
InventoryNet
|
28083 | USD |
CY2016Q4 | us-gaap |
Inventory Net
InventoryNet
|
12932 | USD |
CY2017Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
8727 | USD |
CY2016Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
3648 | USD |
CY2017Q3 | us-gaap |
Assets Current
AssetsCurrent
|
1857751 | USD |
CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
164063 | USD |
CY2017Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
33359 | USD |
CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
462 | USD |
CY2017Q3 | us-gaap |
Assets
Assets
|
1891110 | USD |
CY2016Q4 | us-gaap |
Assets
Assets
|
164525 | USD |
CY2017Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
299726 | USD |
CY2016Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
72445 | USD |
CY2017Q3 | us-gaap |
Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
|
507041 | USD |
CY2016Q4 | us-gaap |
Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
|
359241 | USD |
CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-197535 | USD |
CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-839252 | USD |
CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-839194 | USD |
CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-198091 | USD |
CY2017Q3 | us-gaap |
Revenues
Revenues
|
15106 | USD |
CY2016Q3 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2017Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
52384 | USD |
CY2016Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
CY2017Q3 | us-gaap |
Gross Profit
GrossProfit
|
-37278 | USD |
CY2016Q3 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
CY2017Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-839052 | USD |
CY2016Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-197335 | USD |
CY2017Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
200 | USD |
CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
200 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-600221 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-1757850 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1749136 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-601047 | USD | |
us-gaap |
Revenues
Revenues
|
26006 | USD | |
us-gaap |
Revenues
Revenues
|
6900 | USD | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
108579 | USD | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
7749 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
-82573 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
-849 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1757250 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-599621 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
600 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
600 | USD | |
CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2016Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | ||
CY2017Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
76843759 | shares |
CY2016Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
48279363 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
59570769 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
45024559 | shares | |
CY2017Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
157876 | USD |
CY2016Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14090 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
207504 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
36271 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
16173 | USD | |
CY2017Q3 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
38767 | USD |
CY2016Q3 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
91643 | USD |
us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
439824 | USD | |
us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
285701 | USD | |
CY2017Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
605273 | USD |
CY2016Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
92358 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1019235 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
298324 | USD | |
CY2017Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
801916 | USD |
CY2016Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
198091 | USD |
us-gaap |
Operating Expenses
OperatingExpenses
|
1666563 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
600198 | USD | |
CY2017Q3 | us-gaap |
Interest Income Related Party
InterestIncomeRelatedParty
|
0 | USD |
CY2016Q3 | us-gaap |
Interest Income Related Party
InterestIncomeRelatedParty
|
750 | USD |
us-gaap |
Interest Income Related Party
InterestIncomeRelatedParty
|
1337 | USD | |
us-gaap |
Interest Income Related Party
InterestIncomeRelatedParty
|
1402 | USD | |
CY2017Q3 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD |
CY2016Q3 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
9593 | USD | |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD | |
CY2017Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
142 | USD |
CY2016Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
756 | USD |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-8114 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1426 | USD | |
CY2017Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
142 | USD |
CY2016Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
142 | USD | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
24 | USD | |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
411181 | USD | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2698173 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-263585 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1644405 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-553453 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-88453 | USD | |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
138753 | USD |
CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
50300 | USD |
us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
1494265 | USD | |
us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
46768 | USD | |
us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-2152 | USD | |
us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
1402 | USD | |
us-gaap |
Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
|
85000 | USD | |
us-gaap |
Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1907990 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-85000 | USD | |
us-gaap |
Depreciation
Depreciation
|
3374 | USD | |
us-gaap |
Depreciation
Depreciation
|
500 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
411181 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
23636 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
15151 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-7749 | USD | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-861377 | USD | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
0 | USD | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
189083 | USD | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-70134 | USD | |
us-gaap |
Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
|
145300 | USD | |
us-gaap |
Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
|
124311 | USD | |
us-gaap |
Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
|
85000 | USD | |
us-gaap |
Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
|
0 | USD | |
cik0001662684 |
Cash Acquired In Reverse Recapitalisation
CashAcquiredInReverseRecapitalisation
|
1859261 | USD | |
cik0001662684 |
Cash Acquired In Reverse Recapitalisation
CashAcquiredInReverseRecapitalisation
|
0 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
19106 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
3600 | USD | |
us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-30000 | USD | |
us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
0 | USD | |
us-gaap |
Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
|
-2000 | USD | |
us-gaap |
Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
|
0 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1600 | USD | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD | |
CY2017Q2 | us-gaap |
Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
|
0.6457 | pure |
CY2017Q3 | cik0001662684 |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
196643 | USD |
CY2016Q3 | cik0001662684 |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
105733 | USD |
cik0001662684 |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
647328 | USD | |
cik0001662684 |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
301874 | USD | |
CY2017Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
596241 | shares |
CY2016Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1720637 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
782051 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4975441 | shares | |
CY2017Q3 | cik0001662684 |
Working Capital
WorkingCapital
|
1050984 | USD |
CY2017Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
116667 | USD |
CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
18000 | USD |
CY2017Q3 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
12742 | USD |
CY2016Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
36422 | USD |
CY2017Q3 | cik0001662684 |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
32717 | USD |
CY2016Q4 | cik0001662684 |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
6250 | USD |
CY2017Q3 | cik0001662684 |
Credit Card Payable
CreditCardPayable
|
25101 | USD |
CY2016Q4 | cik0001662684 |
Credit Card Payable
CreditCardPayable
|
9521 | USD |
CY2017Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
23884 | USD |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2252 | USD |
CY2017Q3 | cik0001662684 |
Accrued Research And Development Expenses Related Parties
AccruedResearchAndDevelopmentExpensesRelatedParties
|
507041 | USD |
CY2016Q4 | cik0001662684 |
Accrued Research And Development Expenses Related Parties
AccruedResearchAndDevelopmentExpensesRelatedParties
|
351540 | USD |
CY2017Q3 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
0 | USD |
CY2016Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
7701 | USD |
CY2017Q3 | cik0001662684 |
Accounts Payable And Other Accrued Liabilities Current Related Parties
AccountsPayableAndOtherAccruedLiabilitiesCurrentRelatedParties
|
507041 | USD |
CY2016Q4 | cik0001662684 |
Accounts Payable And Other Accrued Liabilities Current Related Parties
AccountsPayableAndOtherAccruedLiabilitiesCurrentRelatedParties
|
359241 | USD |
CY2017Q3 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
32000 | USD |
CY2017Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
464846 | USD |
CY2017Q3 | cik0001662684 |
Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Not Yet Recognized Subject To Remeasurement
EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedSubjectToRemeasurement
|
341520 | USD |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P7M6D | ||
CY2017Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2017Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2017Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
77440000 | shares |
CY2017Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
77440000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
50000000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50000000 | shares |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the financial statements. The Company’s significant estimates used in these financial statements include, but are not limited to, stock-based compensation, the collectability of receivables, inventory valuations, the recoverability and useful lives of long-lived assets and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Concentrations of Credit Risk</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company maintains cash with major financial institutions. Cash held in US bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font> at each institution. There were aggregate uninsured cash balances of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,225,642</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font> at September 30, 2017 and December 31, 2016, respectively.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During the nine months ended September 30, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of the Company’s revenues were generated from Customer A. During the three months ended September 30, 2017, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 76</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 24</font>% of the Company’s revenues were generated from Customer C and Customer A, respectively. During the nine months ended September 30, 2017, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 44</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 42</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14</font>% of the Company’s revenues were generated from Customer C, Customer B and Customer A, respectively. As of September 30, 2017, receivables from Customer C, Customer B and Customer A comprised <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 44</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 42</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14</font>%, respectively, of  the Company’s total accounts receivable. As of December 31, 2016, a receivable from Customer A comprised <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of the Company’s total account receivable.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
550000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
550000 | USD | |
CY2017Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
CY2017Q3 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
1225642 | USD |
CY2016Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
0 | USD |
CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q3 | cik0001662684 |
Accruedpayrollandvacation
Accruedpayrollandvacation
|
88615 | USD |
CY2016Q4 | cik0001662684 |
Accruedpayrollandvacation
Accruedpayrollandvacation
|
0 | USD |
us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
0 | USD |